129 related articles for article (PubMed ID: 12105103)
1. Calpain upregulation and neuron death in spinal cord of MPTP-induced parkinsonism in mice.
Chera B; Schaecher KE; Rocchini A; Imam SZ; Ray SK; Ali SF; Banik NL
Ann N Y Acad Sci; 2002 Jun; 965():274-80. PubMed ID: 12105103
[TBL] [Abstract][Full Text] [Related]
2. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.
Chera B; Schaecher KE; Rocchini A; Imam SZ; Sribnick EA; Ray SK; Ali SF; Banik NL
Brain Res; 2004 May; 1006(2):150-6. PubMed ID: 15051518
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.
Samantaray S; Knaryan VH; Shields DC; Cox AA; Haque A; Banik NL
Mol Neurobiol; 2015 Oct; 52(2):1054-66. PubMed ID: 26108182
[TBL] [Abstract][Full Text] [Related]
5. Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease.
Ray SK; Wilford GG; Ali SF; Banik NL
Ann N Y Acad Sci; 2000 Sep; 914():275-83. PubMed ID: 11085327
[TBL] [Abstract][Full Text] [Related]
6. Extranigral neurodegeneration in Parkinson's disease.
Samantaray S; Butler JT; Ray SK; Banik NL
Ann N Y Acad Sci; 2008 Oct; 1139():331-6. PubMed ID: 18991878
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord.
Zhang J; Wang M; Zhao Y; Zhang Y; Gao Y; Zhang X; Yang G
Neurosci Lett; 2022 Jun; 781():136669. PubMed ID: 35490905
[TBL] [Abstract][Full Text] [Related]
8. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
[TBL] [Abstract][Full Text] [Related]
9. Motor Neurons Pathology After Chronic Exposure to MPTP in Mice.
Vivacqua G; Biagioni F; Busceti CL; Ferrucci M; Madonna M; Ryskalin L; Yu S; D'Este L; Fornai F
Neurotox Res; 2020 Feb; 37(2):298-313. PubMed ID: 31721049
[TBL] [Abstract][Full Text] [Related]
10. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
11. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
12. Chronic MPTP in Mice Damage-specific Neuronal Phenotypes within Dorsal Laminae of the Spinal Cord.
Biagioni F; Vivacqua G; Lazzeri G; Ferese R; Iannacone S; Onori P; Morini S; D'Este L; Fornai F
Neurotox Res; 2021 Apr; 39(2):156-169. PubMed ID: 33206341
[TBL] [Abstract][Full Text] [Related]
13. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
14. Potential neuroprotective effect of low dose whole-body gamma-irradiation against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic toxicity in C57 mice.
Liang Y; Li S; Zou Q; Su B
Neurosci Lett; 2006 Jun; 400(3):213-7. PubMed ID: 16540245
[TBL] [Abstract][Full Text] [Related]
15. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
[TBL] [Abstract][Full Text] [Related]
16. Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease.
Haque A; Samantaray S; Knaryan VH; Capone M; Hossain A; Matzelle D; Chandran R; Shields DC; Farrand AQ; Boger HA; Banik NL
Exp Neurol; 2020 Aug; 330():113315. PubMed ID: 32302678
[TBL] [Abstract][Full Text] [Related]
17. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
18. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic molecules and MPTP-induced cell death.
Nicotra A; Parvez S
Neurotoxicol Teratol; 2002; 24(5):599-605. PubMed ID: 12200191
[TBL] [Abstract][Full Text] [Related]
20. Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
Naskar A; Prabhakar V; Singh R; Dutta D; Mohanakumar KP
J Pineal Res; 2015 Apr; 58(3):262-74. PubMed ID: 25626558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
